Mark Verratti - Mar 14, 2024 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Commercial Officer
Signature
By: Justin Hunter For: Mark Verratti
Stock symbol
MYGN
Transactions as of
Mar 14, 2024
Transactions value $
-$77,996
Form type
4
Date filed
3/18/2024, 04:45 PM
Previous filing
Oct 10, 2023
Next filing
Mar 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $0 +58.6K +23.48% $0.00 308K Mar 14, 2024 Direct F1
transaction MYGN Common Stock Tax liability -$78K -3.69K -1.2% $21.16 305K Mar 15, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.
F2 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 15, 2024.